Cart

0

Stocks

“Cancer Drug Bet Pays Off for Biotech CEO With 3,600% Stock Surge”

“When Jan Skvarka joined biotechnology firm Trillium Therapeutics Inc. as chief executive officer, he made a big bet to reshape the company and went all-in on a cancer treatment platform. Now, he’s reaping the rewards.

It was the gamble of a lifetime for the 53-year-old CEO, who decided to shutter the drug developer’s lead program on treating tumors directly and instead focus on cancer-fighting technology for patients with different blood cancers. Investors cheered, rewarding him with a 3,600% stock-surge since he joined the company a year ago…”

https://finance.yahoo.com/news/cancer-drug-bet-pays-off-150140350.html

Wow, there are some very happy people who invested a year ago.

Leave a Reply